 |
Manchester Chemical Biology Network
Providing a unique cross disciplinary forum for uniting scientists from across chemical, biological and medical science with user organisations |
|
Focus of the Collaborative Network
Computational and Chemical Tools
|
Target Elucidation and Modulation |
 |
 |
Chemical Systems Biology
|
Biopharmaceuticals and Nanomedicine |
 |
 |
|
Academic Groups and Research ExpertiseThe Network unites researchers with interests in chemical biology from across the University from the Faculties of Engineering and Physical Sciences, Life Sciences and Human and Medical Sciences.
Coordinated from the Manchester Interdisciplinary Biocentre , the Network will also unite activity from a number of Research Centres and Institutes. |
 |
Industrial Partners & End Users
AstraZeneca, Biotica, Oxyrane, Morvus, Imagen Biotech, Pfizer, GSK, Syngenta, Senexis, Peakdale Molecular and Manchester Biomedical Research Centre |
| Steering Committee | |
Led by Jason Micklefield, the network is managed through a steering committee with representaion from across the University of Manchester (Sabine Flitsch, Steve Taylor and David Ray) and Industrial Partners Network Administrator - Ros Le Feuvre |
|
Events The next main MCBN event will take in June 2012 If you would like any smaller events please contact Ros Le Feuvre r.a.le-feuvre@manchester.ac.uk |